Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
2.
Mol Pharmacol ; 59(3): 434-41, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11179436

ABSTRACT

Using a genomics-based reverse pharmacological approach for screening orphan G-protein coupled receptors, we have identified and cloned a novel high-affinity histamine receptor. This receptor, termed AXOR35, is most closely related to the H3 histamine receptor, sharing 37% protein sequence identity. A multiple responsive element/cyclic AMP-responsive element-luciferase reporter assay was used to identify histamine as a ligand for AXOR35. When transfected into human embryonic kidney 293 cells, the AXOR35 receptor showed a strong, dose-dependent calcium mobilization response to histamine and H3 receptor agonists including imetit and immepip. Radioligand binding confirmed that the AXOR35 receptor was a high-affinity histamine receptor. The pharmacology of the AXOR35 receptor was found to closely resemble that of the H3 receptor; the major difference was that (R)-alpha-methylhistamine was a low potency agonist of the AXOR35 receptor. Thioperamide is an antagonist at AXOR 35. Expression of AXOR35 mRNA in human tissues is highest in peripheral blood mononuclear cells and in tissues likely to contain high concentrations of blood cells, such as bone marrow and lung. In situ hybridization analysis of a wide survey of mouse tissues showed that mouse AXOR35 mRNA is selectively expressed in hippocampus. The identification and localization of this new histamine receptor will expand our understanding of the physiological and pathological roles of histamine and may provide additional opportunities for pharmacological modification of these actions.


Subject(s)
Histamine/metabolism , Receptors, Histamine/genetics , Amino Acid Sequence , Animals , Calcium/metabolism , Cloning, Molecular , Dose-Response Relationship, Drug , Gene Expression , Genes, Reporter , Humans , Luciferases , Mice , Molecular Sequence Data , Radioligand Assay , Receptors, Histamine/metabolism , Receptors, Histamine H3/chemistry , Receptors, Histamine H3/metabolism , Sequence Homology, Amino Acid , Tissue Distribution , Tritium
3.
Am J Physiol Cell Physiol ; 280(3): C677-88, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11171587

ABSTRACT

Fully grown oocytes of Xenopus laevis undergo resumption of the meiotic cycle when treated with the steroid hormone progesterone. Previous studies have shown that meiotic maturation results in profound downregulation of specific endogenous membrane proteins in oocytes. To determine whether the maturation impacts the functional properties of exogenously expressed membrane proteins, we used cut-open recordings from Xenopus oocytes expressing several types of Na(+) and K(+) channels. Treatment of oocytes with progesterone resulted in a downregulation of heterologously expressed Na(+) and K(+) channels without a change in the kinetics of the currents. The time course of progesterone-induced ion channel inhibition was concentration dependent. Complete elimination of Na(+) currents temporally coincided with development of germinal vesicle breakdown, while elimination of K(+) currents was delayed by approximately 2 h. Coexpression of human beta(1)-subunit with rat skeletal muscle alpha-subunit in Xenopus oocytes did not prevent progesterone-induced downregulation of Na(+) channels. Addition of 8-bromo-cAMP to oocytes or injection of heparin before progesterone treatment prevented the loss of expressed currents. Pharmacological studies suggest that the inhibitory effects of progesterone on expressed Na(+) and K(+) channels occur downstream of the activation of cdc2 kinase. The loss of channels is correlated with a reduction in Na(+) channel immunofluorescence, pointing to a disappearance of the ion channel-forming proteins from the surface membrane.


Subject(s)
Oocytes/metabolism , Potassium Channel Blockers , Progesterone/pharmacology , Sodium Channel Blockers , Animals , CDC2 Protein Kinase/physiology , Cell Membrane/metabolism , Cyclic AMP/physiology , Cytoplasm/metabolism , Cytoskeleton/physiology , Down-Regulation , Electric Conductivity , Female , Inositol 1,4,5-Trisphosphate/physiology , Potassium Channels/physiology , Proteins/metabolism , Sodium Channels/physiology , Xenopus
4.
Science ; 286(5448): 2358-61, 1999 Dec 17.
Article in English | MEDLINE | ID: mdl-10600750

ABSTRACT

Nerve growth factor (NGF) and other neurotrophins support survival of neurons through processes that are incompletely understood. The transcription factor CREB is a critical mediator of NGF-dependent gene expression, but whether CREB family transcription factors regulate expression of genes that contribute to NGF-dependent survival of sympathetic neurons is unknown. CREB-mediated gene expression was both necessary for NGF-dependent survival and sufficient on its own to promote survival of sympathetic neurons. Moreover, expression of Bcl-2 was activated by NGF and other neurotrophins by a CREB-dependent transcriptional mechanism. Overexpression of Bcl-2 reduced the death-promoting effects of CREB inhibition. Together, these data support a model in which neurotrophins promote survival of neurons, in part through a mechanism involving CREB family transcription factor-dependent expression of genes encoding prosurvival factors.


Subject(s)
Cyclic AMP Response Element-Binding Protein/metabolism , Gene Expression Regulation , Nerve Growth Factor/pharmacology , Neurons/cytology , Sympathetic Nervous System/cytology , Animals , Apoptosis , Axons/drug effects , Axons/metabolism , Brain-Derived Neurotrophic Factor/pharmacology , Cell Nucleus/metabolism , Cell Survival , Cells, Cultured , Cyclic AMP Response Element-Binding Protein/antagonists & inhibitors , Genes, bcl-2 , Genetic Vectors , Neurons/drug effects , Neurons/metabolism , PC12 Cells , Promoter Regions, Genetic , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Recombinant Fusion Proteins/metabolism , Signal Transduction , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/metabolism , Transfection
5.
J Biol Chem ; 268(35): 26645-9, 1993 Dec 15.
Article in English | MEDLINE | ID: mdl-8253795

ABSTRACT

Over 40 mutations in the rhodopsin gene have been identified in patients with autosomal dominant retinitis pigmentosa. Twenty-one of these mutations have been introduced into a human rhodopsin cDNA by site-directed mutagenesis, and the encoded proteins have been produced by transfection of a human embryonic kidney cell line (293S). Three of the mutant proteins (G51V, V345M, and P347S) resemble the wild type in yield, regenerability with 11-cis-retinal, and accumulation in the plasma membrane (class I). The remaining 18 mutant proteins are produced at lower levels, regenerate variably or not at all with 11-cis-retinal, and accumulate partially or predominantly in the endoplasmic reticulum (class II). Together with an earlier analysis of 13 mutant rhodopsins (Sung, C.-H., Schneider, B., Agarwal, N., Papermaster, D.S., and Nathans, J. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 8840-8844), these experiments define distinct classes of biochemical defects in human rhodopsin and further show that amino acid substitutions in class II reside within the transmembrane and extracellular domains, whereas class I mutants cluster in the first transmembrane domain and at the extreme carboxyl terminus.


Subject(s)
Genes, Dominant , Mutation , Retinitis Pigmentosa/genetics , Rhodopsin/genetics , DNA, Complementary , Humans , Membrane Proteins/chemistry , Membrane Proteins/genetics , Peptides/chemistry , Rhodopsin/chemistry
6.
Am J Hum Genet ; 53(1): 80-9, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8317502

ABSTRACT

Ten rhodopsin mutations have been found in a screen of 282 subjects with retinitis pigmentosa (RP), 76 subjects with Leber congenital amaurosis, and 3 subjects with congenital stationary night blindness. Eight of these mutations (gly51-to-ala, val104-to-ile, gly106-to-arg, arg135-to-gly, cys140-to-ser, gly188-to-glu, val209-to-met, and his211-to-arg) produce amino acid substitutions, one (gln64-to-ter) introduces a stop codon, and one changes a guanosine in the intron 4 consensus splice donor sequence to thymidine. Cosegregation of RP with gln64-to-ter, gly106-to-arg, arg135-to-gly, cys140-to-ser, gly188-to-glu, his211-to-arg, and the splice site guanosine-to-thymidine indicates that these mutations are likely to cause retinal disease. Val104-to-ile does not cosegregate and is therefore unlikely to be related to retinal disease. The relevance of gly51-to-ala and val209-to-met remains to be determined. The finding of gln64-to-ter in a family with autosomal dominant RP is in contrast to a recent report of a recessive disease phenotype associated with the rhodopsin mutation glu249-to-ter. In the present screen, all of the mutations that cosegregate with retinal disease were found among patients with RP. The mutations described here bring to 35 the total number of amino acid substitutions identified thus far in rhodopsin that are associated with RP. The distribution of the substitutions along the polypeptide chain is significantly nonrandom: 63% of the substitutions involve those 19% of amino acids that are identical among vertebrate visual pigments sequenced to date.


Subject(s)
Mutation , Retinitis Pigmentosa/genetics , Rhodopsin/genetics , Alleles , Blindness/congenital , Blindness/genetics , DNA Mutational Analysis , Female , Gene Frequency , Humans , Male , Night Blindness/genetics , Pedigree , Polymerase Chain Reaction , Protein Conformation , Rhodopsin/chemistry , Rhodopsin/physiology
8.
Proc Natl Acad Sci U S A ; 88(15): 6481-5, 1991 Aug 01.
Article in English | MEDLINE | ID: mdl-1862076

ABSTRACT

DNA samples from 161 unrelated patients with autosomal dominant retinitis pigmentosa were screened for point mutations in the rhodopsin gene by using the polymerase chain reaction and denaturing gradient gel electrophoresis. Thirty-nine patients were found to carry 1 of 13 different point mutations at 12 amino acid positions. The presence or absence of the mutations correlated with the presence or absence of retinitis pigmentosa in 174 out of 179 individuals tested in 17 families. The mutations were absent from 118 control subjects with normal vision.


Subject(s)
DNA/genetics , Genes, Dominant , Genes , Mutation , Retinitis Pigmentosa/genetics , Rhodopsin/metabolism , Base Sequence , DNA/isolation & purification , Female , Humans , Male , Molecular Sequence Data , Night Blindness/etiology , Night Blindness/genetics , Nucleic Acid Hybridization , Oligonucleotide Probes , Pedigree , Polymerase Chain Reaction , Visual Fields
9.
Science ; 245(4920): 831-8, 1989 Aug 25.
Article in English | MEDLINE | ID: mdl-2788922

ABSTRACT

Blue cone monochromacy is a rare X-linked disorder of color vision characterized by the absence of both red and green cone sensitivities. In 12 of 12 families carrying this trait, alterations are observed in the red and green visual pigment gene cluster. The alterations fall into two classes. One class arose from the wild type by a two-step pathway consisting of unequal homologous recombination and point mutation. The second class arose by nonhomologous deletion of genomic DNA adjacent to the red and green pigment gene cluster. These deletions define a 579-base pair region that is located 4 kilobases upstream of the red pigment gene and 43 kilobases upstream of the nearest green pigment gene; this 579-base pair region is essential for the activity of both pigment genes.


Subject(s)
Color Vision Defects/genetics , Adolescent , Adult , Base Sequence , Child , Child, Preschool , Chromosome Deletion , DNA/analysis , Female , Humans , Male , Molecular Sequence Data , Mutation , Nucleic Acid Hybridization , Retinal Pigments/genetics , Thalassemia/genetics , X Chromosome
SELECTION OF CITATIONS
SEARCH DETAIL
...